References: Antiphospholipid syndrome

  • Arnaud L, Mathian A, Ruffatti A, Erkan D, Tektonidou M, Cervera R, et al. Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmun Rev 2014;13(3):281-91. https://www.ncbi.nlm.nih.gov/pubmed/24189281
  • Bala MM, Celinska-Lowenhoff M, Szot W, Padjas A, Kaczmarczyk M, Swierz MJ, et al. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Cochrane Database Syst Rev 2020;10(10):CD012169. https://www.ncbi.nlm.nih.gov/pubmed/33045766
  • Barbhaiya M, Zuily S, Naden R, Hendry A, Manneville F, Amigo MC, et al. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. Arthritis Rheumatol 2023;75(10):1687-702. https://www.ncbi.nlm.nih.gov/pubmed/37635643
  • Branch DW. What's new in obstetric antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2019;2019(1):421-5. https://www.ncbi.nlm.nih.gov/pubmed/31808896
  • Carmi O, Berla M, Shoenfeld Y, Levy Y. Diagnosis and management of catastrophic antiphospholipid syndrome. Expert Rev Hematol 2017;10(4):365-74. https://www.ncbi.nlm.nih.gov/pubmed/28277850
  • Cervera R, Bucciarelli S, Plasin MA, Gomez-Puerta JA, Plaza J, Pons-Estel G, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the "CAPS Registry". J Autoimmun 2009;32(3-4):240-5. https://www.ncbi.nlm.nih.gov/pubmed/19324520
  • Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46(4):1019-27. https://www.ncbi.nlm.nih.gov/pubmed/11953980
  • de Jesus GR, Sciascia S, Andrade D, Barbhaiya M, Tektonidou M, Banzato A, et al. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG 2019;126(5):656-61. https://www.ncbi.nlm.nih.gov/pubmed/30222236
  • Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L, et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheumatology 2007;56(7):2382-91. https://www.ncbi.nlm.nih.gov/pubmed/17599766
  • Erkan D, Merrill JT, Yazici Y, Sammaritano L, Buyon JP, Lockshin MD. High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis Rheum 2001;44(6):1466-7. https://www.ncbi.nlm.nih.gov/pubmed/11407709
  • Garcia D, Erkan D. Diagnosis and Management of the Antiphospholipid Syndrome. N Engl J Med 2018;378(21):2010-21. https://www.ncbi.nlm.nih.gov/pubmed/29791828
  • Jiang H, Wang CH, Jiang N, Li J, Wu CY, Wang Q, et al. Clinical characteristics and prognosis of patients with isolated thrombotic vs. obstetric antiphospholipid syndrome: a prospective cohort study. Arthritis Res Ther 2021;23(1):138. https://www.ncbi.nlm.nih.gov/pubmed/33964976
  • Lim W. Prevention of thrombosis in antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 2016;2016(1):707-13. https://www.ncbi.nlm.nih.gov/pubmed/27913550
  • Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000;15(2):145-51. https://www.ncbi.nlm.nih.gov/pubmed/10968901
  • Pons-Estel GJ, Andreoli L, Scanzi F, Cervera R, Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. Journal of Autoimmunity 2017;76:10-20. https://www.ncbi.nlm.nih.gov/pubmed/27776934
  • Sammaritano LR. Antiphospholipid syndrome. Best Pract Res Clin Rheumatol 2020;34(1):101463. https://www.ncbi.nlm.nih.gov/pubmed/31866276
  • Sammaritano LR, Bermas BL, Chakravarty EE, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol 2020;72(4):529-56. https://www.ncbi.nlm.nih.gov/pubmed/32090480
  • Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thromb Res 2019;181 Suppl 1:S41-S6. https://www.ncbi.nlm.nih.gov/pubmed/31477227
  • Spaanderman M, Ghossein-Doha C. Obstetric APS and thrombosis; modelling future risks. BJOG 2019;126(5):662. https://www.ncbi.nlm.nih.gov/pubmed/30592794
  • Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Annals of the Rheumatic Diseases 2019;78(10):1296-304. https://www.ncbi.nlm.nih.gov/pubmed/31092409
  • Tonello M, Calligaro A, Favaro M, Del Ross T, Veronese P, Salvan E, et al. The first thrombotic event in purely obstetric antiphospholipid syndrome patients and in antiphospholipid antibody carriers: comparison of incidence and characteristics. Arch Gynecol Obstet 2021;303(2):455-61. https://www.ncbi.nlm.nih.gov/pubmed/32880711
  • Uthman I, Noureldine MHA, Ruiz-Irastorza G, Khamashta M. Management of antiphospholipid syndrome. Ann Rheum Dis 2019;78(2):155-61. https://www.ncbi.nlm.nih.gov/pubmed/30282668
  • Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus 1998;7(2_suppl):132-4. https://journals.sagepub.com/doi/10.1177/096120339800700229
  • Williams B, Saseen JJ, Trujillo T, Palkimas S. Direct oral anticoagulants versus warfarin in patients with single or double antibody-positive antiphospholipid syndrome. J Thromb Thrombolysis 2022;54(1):67-73. https://www.ncbi.nlm.nih.gov/pubmed/34817786
  • Zuily S, Huttin O, Mohamed S, Marie PY, Selton-Suty C, Wahl D. Valvular heart disease in antiphospholipid syndrome. Curr Rheumatol Rep 2013;15(4):320. https://www.ncbi.nlm.nih.gov/pubmed/23456852